Search Results

You searched for : EuropeanCommission  

European Commission approves Teysuno in metastatic colorectal cancer

Latest Corporate news updates; Pharma Feb 3rd 2022...
Feb 03

GSK and Vir Biotechnology announce joint procurement agreement with European Commission for COVID-19 treatment, Sotrovimab

Latest pharma news update...
Aug 02

Roche’s Tecentriq approved by European Commission for metastatic non-small cell lung cancer

Tecentriq is now the first and only single-agent cancer immunotherapy with three dosing options...
May 08

Xeris Pharmaceuticals receives approval from the European Commission for Ogluo

Ogluo (Glucagon) is indicated treatment of severe hypoglycemia...
Feb 15

AtraZeneca's Imfinzi approved in the EU for less-frequent, fixed-dose use in unresectable non-small cell lung cancer

New option extends dosing from two to four weeks, reducing medical visits and improving patient convenience ...
Jan 15

Elevar Therapeutic collaborates with Inceptua Group for commercialization of Apealea in Europe

Inceptua will have exclusive rights to distribute and commercialize Apealea in Europe...
Dec 28

European Commission approves Roche’s Phesgo for people with HER2-positive breast cancer

Subcutaneous administration is preferred by patients, physicians and healthcare providers, and is associated with a reduction in healthcare costs ...
Dec 23

Blueprint Medicines submits sNDA to USFDA for AYVAKIT for the treatment of advanced systemic mastocytosis

Blueprint Medicines requested priority review for this application, which, if granted, could result in a six-month review process...
Dec 18

Eisai receives approval for indication expansion of anti-epileptic agent fycompa for use in pediatric patients

...
Dec 01

European Commission approves Supemtek® (quadrivalent recombinant influenza vaccine) for the prevention of influenza in adults aged 18 years and older

The European Commission has granted marketing authorization for Supemtek®, a quadrivalent (four-strain) recombinant influenza vaccine, for the prevention of influenza in adults aged 18 ...
Nov 20

Eisai receives approval for indication expansion of anti-epileptic agent fycompa for use in pediatric patients

The approval was based on the results of Phase III and Phase II clinical studies conducted globally to evaluate Fycompa as an adjunctive therapy in ...
Nov 16

Bristol Myers Squibb Receives European Commission approval for Opdivo plus Yervoy for treatment of Lung Cancer

European Commission decision marks the first time a dual immunotherapy with limited chemotherapy is approved for patients with non-small cell lung cancer in the ...
Nov 09

European Commission approves Roche’s Tecentriq in combination with Avastin for the treatment of people with the most common form of liver cancer

European Commission approves Roche’s Tecentriq in combination with Avastin for the treatment of people with the most common form of liver cancer....
Nov 02

Passage Bio’s PBGM01 receives Orphan Drug Designation from EMA for treatment of GM1 Gangliosidosis

...
Oct 27

Novartis gets European Commission approval for Enerzair Breezhaler

Novartis gets European Commission approval For Enerzair Breezhaler asthma treatment ...
Jul 09

AbbVie submits regulatory applications to FDA and EMA for RINVOQ

RINVOQ will be used for the treatment of adults with Active Psoriatic Arthritis...
Jun 08

EC approves subcutaneous formulation of Entyvio for maintenance therapy in adults with Crohn's disease or Ulcerative Colitis

...
May 08

17 Matching result(s) found!

-Advertisements-




Trending Now

No health, gender and economic justice without ending wars, invasions and genocidesJuly 19, 2025
Venus Remedies Secures WHO GDP Endorsement for Best-in-Class Pharma LogisticsJuly 18, 2025
Single Surgeon Performs 17 Joint Replacements in 8 Hours at CARE Banjara, Setting New Benchmark in Orthopedic ExcellenceJuly 17, 2025
Sterling Hospitals Rajkot Achieves a Medical Milestone: Successfully Treats Rare and Life-Threatening Heart Condition RSOV Without Open Heart SurgeryJuly 17, 2025
Vidyadhan Alumni and Students Successfully Host Third Annual Blood Donation DriveJuly 17, 2025
HOSMAC Signs MoU with Gulf Medical University as Industry Partner to Strengthen Healthcare Education and CollaborationJuly 17, 2025
Why Teens Can’t Wake Up Early: The Hidden Problem of School TimingsJuly 17, 2025
Code Blue to Code Smart: How AI is Reshaping ICU Risk StratificationJuly 17, 2025
TERN Group Launches Its 7th Training Centre - and First Dedicated to Japanese Language & Careers - in GuwahatiJuly 16, 2025
Sri Sathya Sai Heart Hospital Ahmedabad and Rajkot signed an MOU with Gujarat Health Department for free heart surgery for needy children and adults July 16, 2025
No health without rights, says Shobha Shukla SDG-3 Lead Discussant at UN meetJuly 15, 2025
30 Minutes To Freedom, Robotic Surgery Ends 89-YO’s Swallowing NightmareJuly 15, 2025
Himalaya Wellness Champions Bhringaraja in New Anti-Hair Fall Campaign with a Tale of FriendshipJuly 15, 2025
ViiV Healthcare and Medicines Patent Pool extends voluntary licensing agreement to enable access to long-acting injectable HIV treatment July 15, 2025
Reforming global financial architecture is critical for gender equality and right to healthJuly 14, 2025
Francesco Arezzo takes office as president of Rotary InternationalJuly 14, 2025
CBM India Highlights Inclusive Eye Health at VISION 2020: The Right to Sight – INDIA 19th Annual ConferenceJuly 14, 2025
Crompton Introduces Ameo Fresh Nutri Blender, Reinforcing Its Promise of ‘Healthy Choices Made Easy’July 14, 2025
NMC Notifies Medical Institutions (Qualifications of Faculty) Regulations, 2025 to Expand Medical Education Capacity and Strengthen Faculty Availability July 14, 2025
India’s Roads, India’s Pain: Healing Beyond the HospitalJuly 14, 2025